Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model

Structure and organization of paramyxovirus particles

(2017) Robert M Cox et al.   Current Opinion in Virology

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma

(2015) Pascal Buijs et al.   Viruses-Basel

Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy

(2014) Fu-Liang Bai et al.   CANCER BIOLOGY & THERAPY

Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection

(2014) P R A Buijs et al.   CANCER GENE THERAPY

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

(2014) Carolien A. Koks et al.   INTERNATIONAL JOURNAL OF CANCER

Newcastle disease virus Malaysian strain AF2240 induces apoptosis in MCF-7 human breast carcinoma cells at an early stage of the virus life cycle

(2013) MOHAMED GHRICI et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication

(2012) Chunchun Meng et al.   ARCHIVES OF VIROLOGY

Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity

(2012) B. Yaacov et al.   JOURNAL OF GENERAL VIROLOGY

NDV-induced apoptosis in absence of Bax; evidence of involvement of apoptotic proteins upstream of mitochondria

(2012) Aidin Molouki et al.   Virology Journal

Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus

(2011) Jianchun Bian et al.   ARCHIVES OF VIROLOGY

The matrix (M) protein of newcastle disease virus binds to human bax through its BH3 domain

(2011) Aidin Molouki et al.   Virology Journal

Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer

(2010) Pingdong Li et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Production of Newcastle Disease Virus by Vero Cells Grown on Cytodex 1 Microcarriers in a 2-Litre Stirred Tank Bioreactor

(2010) Mohd Azmir Arifin et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer

(2010) Kyo Young Song et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Type I Interferon-Sensitive Recombinant Newcastle Disease Virus for Oncolytic Virotherapy

(2010) S. Elankumaran et al.   JOURNAL OF VIROLOGY

Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus

(2010) J Puhlmann et al.   ONCOGENE

Newcastle disease: Evolution of genotypes and the related diagnostic challenges

(2009) Patti J. Miller et al.   INFECTION GENETICS AND EVOLUTION

The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin

(2009) I. Lazar et al.   JOURNAL OF VIROLOGY

Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses

(2009) Dmitriy Zamarin et al.   MOLECULAR THERAPY

Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma

(2009) Jennifer Altomonte et al.   MOLECULAR THERAPY

Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis

(2009) P.V. Ravindra et al.   VIRUS RESEARCH